Jonas Abrahamsson
Overview
Explore the profile of Jonas Abrahamsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
2508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taalas T, Oskarsson T, Heyman M, Lund B, Lepik K, Vaitkeviciene G, et al.
Haematologica
. 2025 Feb;
PMID: 39973352
Age and sex have historically been associated with differences in acute lymphoblastic leukemia (ALL) survival. In the NOPHO ALL2008 trial, patients aged 1-45 years with BCR::ABL1-negative B-precursor and Tcell ALL...
2.
Schafer Hackenhaar F, Refhagen N, Hagleitner M, van Leeuwen F, Marquart H, Madsen H, et al.
Blood
. 2025 Jan;
PMID: 39841000
Current intensive treatment of pediatric T-cell acute lymphoblastic leukemia (T-ALL) has substantial side-effects, highlighting a need for novel biomarkers to improve risk stratification. Canonical biomarkers such as genetics and immunophenotype...
3.
Tregnago C, Benetton M, Ries R, Peplinski J, Alonzo T, Stirewalt D, et al.
J Clin Oncol
. 2024 Dec;
43(8):972-984.
PMID: 39621969
Purpose: Several genomic subsets of mutations with varying sequences (type A, B, D, etc) have been identified. Despite molecular heterogeneity, mutations cumulatively portend a more favorable outcome, but biology and...
4.
Ostlund A, Waraky A, Staffas A, Sjogren H, De Moerloose B, Arad-Cohen N, et al.
Genes Chromosomes Cancer
. 2024 Nov;
63(11):e70003.
PMID: 39508359
Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is a recurrent translocation in AML in infants or very young children and was recently included in the World Health Organization (WHO) Classification of...
5.
Hakansson A, Andersson A, Abrahamsson J, Stenmarker M
Front Oncol
. 2024 Sep;
14:1395841.
PMID: 39220655
Aim: To study Swedish pediatric oncologists' practical and emotional experiences of referring, including and/or treating children in early-phase clinical trials. Methods: A nationwide study was conducted using a mixed-method approach....
6.
Fermer J, Jalnas J, Abrahamsson J, Borssen M, Donner I, Henriksson L, et al.
Acta Paediatr
. 2024 Aug;
113(12):2676-2678.
PMID: 39190328
No abstract available.
7.
Zeller B, Arad-Cohen N, Cheuk D, De Moerloose B, Navarro J, Hasle H, et al.
Haematologica
. 2024 May;
109(9):2873-2883.
PMID: 38721737
Hyperleukocytosis in pediatric acute myeloid leukemia (AML) is associated with severe complications and an inferior outcome. We report results on patients with hyperleukocytosis included in the NOPHO-DBH AML 2012 study....
8.
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
van Weelderen R, Harrison C, Klein K, Jiang Y, Abrahamsson J, Alonzo T, et al.
Blood Adv
. 2024 Apr;
8(12):3200-3213.
PMID: 38621200
A comprehensive international consensus on the cytogenetic risk-group stratification of KMT2A-rearranged (KMT2A-r) pediatric acute myeloid leukemia (AML) is lacking. This retrospective (2005-2016) International Berlin-Frankfurt-Münster Study Group study on 1256 children...
9.
Tierens A, Arad-Cohen N, Cheuk D, De Moerloose B, Navarro J, Hasle H, et al.
J Clin Oncol
. 2024 Apr;
42(18):2174-2185.
PMID: 38603646
Purpose: Measurable residual disease (MRD) by using flow cytometry after induction therapy is strongly prognostic in pediatric AML, and hematopoietic stem-cell transplant (hSCT) may counteract a poor response. We designed...
10.
Kallstrom J, Niinimaki R, Fredlund J, Vogt H, Korhonen L, Castor A, et al.
Haematologica
. 2024 Feb;
109(9):2846-2853.
PMID: 38356449
Allopurinol can be used in maintenance therapy (MT) for pediatric acute lymphoblastic leukemia (ALL) to mitigate hepatic toxicity in patients with skewed 6-mercaptopurine metabolism. Allopurinol increases the erythrocyte levels of...